HHS' Thompson Clarifies RU-486 Stance: Is FDA Commissioner In Limbo?
Executive Summary
HHS' interest in the safety of RU-486 does not differ from its interest in the safety of all drug products, HHS Secretary Tommy Thompson maintained during an appearance at the National Press Club April 17.